预计生物标志物市场在 2023 年至 2031 年期间的复合年增长率为 10.1%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。
生物标志物市场报告涵盖了按类型、产品、疾病类型和应用进行的分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供了上述分析和细分的价值。
报告目的
Insight Partners 的《生物标志物市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种商业利益相关者提供见解,例如:
- 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
- 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
- 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。
生物标志物市场细分
类型
- 疗效生物标志物
- 安全生物标志物
- 验证生物标志物
产品
- 软件
- 服务
- 耗材
疾病类型
- 癌症
- 神经系统疾病
- 免疫疾病
- 心血管
- 其他的
应用
- 药物研发
- 个性化医疗
- 诊断发展
- 疾病风险评估
- 其他的
应用
- 药物研发
- 个性化医疗
- 诊断发展
- 疾病风险评估
- 其他的
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
生物标志物市场增长动力
- 慢性疾病推动生物标志物增长:生物标志物市场的主要驱动力包括慢性疾病等日益增长的趋势,包括癌症、心血管疾病和糖尿病。这些疾病主要通过早期检测和个性化治疗来发展,而生物标志物在其中发挥着非常重要的作用。
- 个性化医疗推动市场扩张:个性化医疗趋势推动了生物标志物市场的发展。根据患者个性化资料量身定制的疗法疗效更好,副作用更小。全球范围内基于生物标志物的药物研发项目数量大幅增加,主要集中在肿瘤学和神经病学领域。由于制药公司和研究机构的需求不断增长,该市场的增长伴随着全球市场规模的扩大。
- 基因组学的突破推动生物标志物的发展:基因组学、蛋白质组学和生物信息学的最新突破正在推动生物标志物的发现。通过疾病特异性生物标志物可以更快地进行识别,提高准确性,从而实现更高效的诊断和药物开发。下一代测序和人工智能等技术彻底改变了生物标志物研究,创造了一个相当有利可图的市场。这些进步极大地提高了全球各个角落先进生物标志物平台的市场份额,推动了该行业的发展。
生物标志物市场未来趋势
- 精准医疗依赖生物标志物:生物标志物在精准医疗中被证明是至关重要的,因此可以根据个人的生物学特征制定治疗计划。罗氏和赛默飞世尔等主要参与者正在以生物标志物为基础,研究癌症、心血管和神经系统疾病的诊断方法。在 SWOT 分析中,早期检测和个性化护理是一大优势,但研发成本仍然是一个问题。市场战略越来越注重与生物技术公司的合作。PEST 分析反映了医疗法规促进生物标志物在治疗方法中的整合所产生的良好影响。
- 早期检测推动诊断需求:小型医疗保健系统现在专注于早期疾病检测和预防保健。基于生物标志物的诊断需求越来越大,市场动态表明其在肿瘤学和自身免疫性疾病方面的应用呈上升趋势。诊断试剂盒已由 Bio-Rad Laboratories 等公司进行了创新。尽管监管障碍正在影响非侵入性测试,但机会在于非侵入性测试。PEST 分析捕捉到了政府的支持性政策和研究资金,这些政策和资金推动了主要参与者的市场战略专注于具有成本效益但准确的生物标志物测试。
- 液体活检彻底改变了癌症检测:液体活检是使用非侵入性生物标记物进行癌症检测的快速发展趋势之一。多家市场参与者正在努力打造用于液体活检的早期癌症检测和监测平台,其中包括 Guardant Health。SWOT 分析表明,存在机遇和挑战。减少患者不适和实时监测或监控身体是其优势。这方面的一个缺点是技术限制。PEST 分析还表明,目前有非常好的法规,并增加了公共资金以增加癌症研究。市场战略通过与医院和研究中心的合作不断发展,以扩大其使用范围。
生物标志物市场机会
- 伴随诊断加速治疗定制:伴随诊断在这个市场中发展尤为迅速,尤其是在北美。这是一种根据伴随诊断领域的个人生物标志物特征定制治疗的程序。最近的统计数据显示,基于肿瘤学和免疫学生物标志物的疗法的监管批准一直在稳步增长。随着公司将制药公司与诊断公司联系起来开发有针对性的治疗方法,竞争形势变得更加严峻,从而为这一细分市场提供了巨大的增长机会。
- 生物标记物可实现神经退行性疾病的早期诊断:生物标记物将日益成为早期发现和治疗阿尔茨海默病和帕金森病等神经系统疾病的重要工具。目前的趋势表明,北美将成为研究机构和生物制药公司投资于生物标记物驱动的诊断解决方案的中心。竞争分析表明,学术界和行业合作日益加强,以快速发现生物标记物,从而为市场向神经退行性疾病的早期诊断和干预转变提供了增长机会。
- 生物标记物提高临床试验效率:竞争分析表明,使用来自试验的生物标记物数据,公司可以在更短的时间内获得批准,并获得更好的患者结果。生物标记物将日益成为临床试验设计和实施的前沿,并且具有非常好的长期前景。
生物标志物市场区域洞察
Insight Partners 的分析师已详细解释了预测期内影响生物标志物市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的生物标志物市场细分和地理位置。
- 获取生物标志物市场的区域特定数据
生物标志物市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | XX 百万美元 |
2031 年市场规模 | XX 百万美元 |
全球复合年增长率(2023 - 2031) | 10.1% |
史料 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
生物标志物市场参与者密度:了解其对业务动态的影响
生物标志物市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在生物标志物市场运营的主要公司有:
- 赛默飞世尔科技公司
- 凯杰公司
- Hologic 公司
- F. 霍夫曼-罗氏有限公司
- 詹森全球服务有限公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取生物标志物市场顶级关键参与者概览
主要卖点
- 全面覆盖:报告全面涵盖了生物标志物市场的产品、服务、类型和最终用户的分析,提供了整体概况。
- 专家分析:报告基于对行业专家和分析师的深入了解而编写。
- 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
- 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。
因此,生物标志物市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Skin Tightening Market
- Malaria Treatment Market
- Nuclear Waste Management System Market
- Explosion-Proof Equipment Market
- Redistribution Layer Material Market
- Collagen Peptides Market
- Environmental Consulting Service Market
- Embolization Devices Market
- Print Management Software Market
- Medical Devices Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies in this market are: Thermo Fisher Scientific Inc, QIAGEN, Hologic Inc, F Hoffmann La Roche Ltd, Janssen Global Services LLC, Siemens Healthcare GmbH, Cisbio Biomarker Technologies Inc, BD
Key future trends in this market are - Advancements in personalized medicine, Increase in cancer diagnostics, AI-driven biomarker discovery
The Biomarkers Market is expected to register a CAGR of 10.1% from 2023-2031.
The major factors impacting the Biomarkers Market are: Rising Prevalence of Chronic Diseases, Growing Focus on Personalized Medicine, and Technological Advancements in Biomarker Discovery
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. Thermo Fisher Scientific Inc.
2. QIAGEN
3. Hologic, Inc.
4. F. Hoffmann-La Roche Ltd
5. Janssen Global Services, LLC
6. Siemens Healthcare GmbH
7. Cisbio
8. Biomarker Technologies, Inc.
9. BD
10. Bio-Rad Laboratories, Inc.
11. Perkinelmer, Inc.
12. Merck Millipore
13. Enzo Biochem, Inc.
14. EKF Diagnostics Holdings, Inc.
15. Meso Scale Diagnostics, LLC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.